News

September 22, 2015 3:45 pm
  In a follow-up to last week's blog about Agent Orange, IMF Chairman Dr. Brian Durie writes that a new report suggesting a link between home pesticide use and the risk of childhood cancers - especially blood cancers such as leukemia and lymphoma -...
September 22, 2015 3:45 pm
Takeda Pharmaceutical Company Limited on September 22, 2015 announced that it will highlight the ixazomib clinical development program during multiple poster sessions at the upcoming 15th International Myeloma Workshop (IMW 2015) to be held in Rome...
September 22, 2015 3:45 pm
  The US Food and Drug Administration (FDA) has agreed for priority review of Amgen’s supplemental new drug application (sNDA) for expanded labeling of Kyprolis (carfilzomib) in relapsed multiple myeloma.
September 16, 2015 10:00 am
Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review status to the New Drug Application (NDA) for ixazomib, the first investigational oral proteasome inhibitor for the...

Pages